FDA Clearance Tracker · P080030-S021
iStent Trabecular Micro-Bypass Stent System
Last checked: Nov 20, 2026Latest source record: May 29, 2018 (this decision)Source: openFDAMethods & limitations
Decided
May 29, 2018
Approved
Time to decision
89 days
Received Mar 1, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P080030-S021
- Device name
- iStent Trabecular Micro-Bypass Stent System
- Applicant
- Glaukos Corporation
- Applicant location
- Laguna Hills, CA
- Received
- Mar 1, 2018
- Decided
- May 29, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P080030
Device type
- Device type
- Intraocular pressure lowering implant (OGO)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for two alternate packaging configurations that include an ophthalmic clip.
Source documents
Other decisions for Glaukos Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K220032 · Decided Aug 2, 2022 · 209 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.